Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Home About Us My Account Personal Library Customer Service    
Welcome Guest
(login/register)
US: 800.298.5699
Int'l: +1.240.747.3093
Quick Search
Advanced Search >
Research Assistance
Send us a request >
Latest Research by Email
Receive email alerts of new market research reports in your industry.
Sign Up Today >
Home > Back to Publisher > Report Information Email a colleague | Printer format

Adult ADHD - Strattera Grows Up

Datamonitor
March 18, 2004
51 Pages - Pub ID: DFMN974984
 
Questions about this report >
Order by fax >
XE.com
Abstract

Table of
Contents
Search Inside
this Report
Related Reports

Title
Published
Price
Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion
By: Datamonitor
Introduction In 2008, seven major market sales of antipsychotics reached $18.2 billion. Datamonitor forecasts the market value to peak in 2011 when it will then succumb to generic erosion, particularly in the US where incursion is  |  more...
10/28/2009       $15,200.00
Substance Abuse & Mental Health Clinics in the US - Industry Market Research Report
By: IBISWorld
Industry Market Research Synopsis This Industry Market Research report from IBISWorld provides a detailed analysis of the Substance Abuse & Mental Health Clinics in the US industry, including key growth trends, statistics, forecasts, the competitive environment  |  more...
Search inside this report
10/21/2009       $825.00
Substance Abuse & Mental Health Facilities in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Substance Abuse & Mental Health Facilities in the US industry. Industry Risk is assumed to be 'the difficulty,  |  more...
Search inside this report
10/17/2009       $825.00
Substance Abuse & Mental Health Clinics in the US - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Substance Abuse & Mental Health Clinics in the US industry. Industry Risk is assumed to be 'the difficulty,  |  more...
Search inside this report
10/17/2009       $825.00
Psychiatric Hospitals in Australia - Industry Risk Rating Report
By: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Psychiatric Hospitals in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business  |  more...
Search inside this report
10/17/2009       $810.00
Antidepressants Market Forecast
By: Datamonitor
Introduction With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial  |  more...
10/13/2009       $15,200.00
Substance Abuse Poisoning Therapy Area Pipeline Report
By: Life Science Analytics (LSA)
Life Science Analytics', Poisoning Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of poisoning drugs by company and by stage as well as  |  more...
Search inside this report
9/14/2009       $1,495.00
Disease and Therapy Review: Generalized Anxiety Disorder
By: Timely Data Resources, Inc.
The Generalized Anxiety Disorder (GAD) Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview  |  more...
Search inside this report
9/1/2009       $750.00
Disease and Therapy Review:Major Depressive Disorder
By: Timely Data Resources, Inc.
The Major Depressive Disorder Disease and Therapy Review provides an overview of the disease and related conditions, with prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment.  |  more...
Search inside this report
9/1/2009       $750.00
The Psychiatric Disease Pipeline: A Strategic Review
By: Decision Resources
Numbers tell the story in psychiatric disease drug development: almost 300 recognized indications, 28% 12-month prevalence that yields large patient populations, strong 7.5% annual sales growth in recent years, sustained franchise sales, tolerance for use  |  more...
7/22/2009       $2,250.00
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 2